Validation of the Molecular International Prognostic Scoring System (IPSS-M) in Patients (Pts) with Myelodysplastic Syndromes/Neoplasms (MDS) Who Underwent Allogenic Stem Cell Transplantation (HSCT)
Tariq Kewan(Yale University), Amer M. Zeidan(Yale Cancer Center), Gail J. Roboz(Cornell University), Maximilian Stahl(Harvard University), Hetty E. Carraway(Cleveland Clinic), David A. Sallman(Moffitt Cancer Center), Constantine Logothetis(Saint Louis University), Amy E. DeZern(Johns Hopkins University), Eunice S. Wang(Roswell Park Comprehensive Cancer Center), Joshua F. Zeidner(University of North Carolina at Chapel Hill), Eric Padron(Moffitt Cancer Center), Maria L. Amaya(University of Colorado Denver), Jessica M. Stempel(University of New Haven), Zhuoer Xie(Mayo Clinic), Ondřej Bláha(Yale University), Michael R. Savona(Vanderbilt University), Mikkael A. Sekeres(University of Miami), Namrata S. Chandhok(Sylvester Comprehensive Cancer Center), Elizabeth A. Griffiths(Roswell Park Comprehensive Cancer Center), Benjamin Rolles(Brigham and Women's Hospital), Hunter Cochran(Washington University in St. Louis), Eytan M. Stein(Memorial Sloan Kettering Cancer Center), Pinkal Desai(NewYork–Presbyterian Hospital), Jan Philipp Bewersdorf(Memorial Sloan Kettering Cancer Center), Jaroslaw P. Maciejewski(Cleveland Clinic), Matteo Giovanni Della Porta(Humanitas University), Rory M. Shallis(Smilow Cancer Hospital), Geoffrey L. Uy(Memorial Sloan Kettering Cancer Center), Amyah C. Harris(Dana-Farber Cancer Institute), Najla H. Al Ali(Moffitt Cancer Center), Andrew M. Brunner(Harvard University), Ameera Rose(Cleveland Clinic), Rami S. Komrokji(Moffitt Cancer Center)
Cited by 1
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k